Table 2.
IBD Type | Distribution of Costs |
---|---|
Crohn’s disease (n=53) | |
Pharmacy-related | |
Infliximab drug cost | 22.6% |
Other pharmacy costs | 23.0% |
Personnel (i.e., nursing, short stay unit staff) | 31.8% |
Other overhead (e.g., facilities, maintenance) | 22.6% |
Non-Drug Cost Per Infusion in CD | 77.4% |
Ulcerative colitis (n=23) | |
Pharmacy-related | |
Infliximab cost | 22.7% |
Other pharmacy costs | 23.1% |
Personnel (i.e., nursing, short stay unit staff) | 31.5% |
Other overhead (e.g., facilities, maintenance) | 22.7% |
Non-Drug Cost Per Infusion in UC | 77.3% |